Cara Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cara Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Cara Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $3.65M, a 360% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.65M +$2.85M +360% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $3.83M +$2.65M +226% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $4.86M +$3.31M +214% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $7.11M +$5.19M +271% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $792K -$1.49M -65.2% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $1.18M -$1.45M -55.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.55M -$1.42M -47.8% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $1.92M -$1.39M -42.1% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.28M -$1.36M -37.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.63M -$1.33M -33.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.97M -$1.31M -30.5% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $3.31M +$656K +24.7% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $3.64M +$816K +28.9% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.96M +$1.09M +37.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $4.28M +$1.24M +40.9% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $2.65M -$538K -16.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $2.83M -$519K -15.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $2.88M -$616K -17.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.04M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $3.19M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $3.34M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $3.49M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.